Smart photopharmacological agents: LaVO<sub>4</sub>:Eu<sup>3+</sup>@vinyl phosphonate combining luminescence imaging and photoswitchable butyrylcholinesterase inhibition-Reference-Cited by-同舟云学术

Smart photopharmacological agents: LaVO₄:Eu³⁺@vinyl phosphonate combining luminescence imaging and photoswitchable butyrylcholinesterase inhibition

Published:2024 Issue:17 Volume:6 Page:4417-4425
ISSN:2516-0230
Container-title:Nanoscale Advances
language:en
Short-container-title:Nanoscale Adv.

Author:

Bikbaeva Gulia¹,Pilip Anna²,Egorova Anastasiya²³^ORCID,Medvedev Vasiliy¹,Mamonova Daria¹,Pankin Dmitrii¹,Kalinichev Alexey¹^ORCID,Mayachkina Natalya²,Bakina Lyudmila²,Kolesnikov Ilya¹^ORCID,Leuchs Gerd⁴^ORCID,Manshina Alina¹^ORCID

Affiliation:

1. St Petersburg State University, 7-9 Universitetskaya Embankment, St Petersburg, 199034, Russia

2. St Petersburg Federal Research Center of the Russian Academy of Sciences (SPC RAS), Scientific Research Centre for Ecological Safety of the Russian Academy of Sciences, Korpusnaya 18, St Petersburg, 197110, Russia

3. St Petersburg State Technological Institute (Technical University), 26, Moskovski Ave., St Petersburg, 190013, Russia

4. Max Planck Institute for the Science of Light, Erlangen, 91058, Germany

Abstract

The first hybrid LaVO4:Eu3+@vinyl phosphonate nanomaterial with a possibility of spatial visualization in addition to photoswitchable and bioactive properties.

Funder

Russian Science Foundation

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/NA/D4NA00389F

Reference47 articles.

1. In Vivo Photopharmacology

2. Photopharmacology: Beyond Proof of Principle

3. Photoswitchable molecules as key ingredients to drive systems away from the global thermodynamic minimum

4. Photopharmacology on Acetylcholinesterase: Novel Photoswitchable Inhibitors with Improved Pharmacological Profiles